openPR Logo
Press release

Global Electrophysiology Devices Market to grow at a CAGR of 9.73% by 2030, Evaluates DelveInsight

08-16-2025 05:36 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Global Electrophysiology Devices Market to grow at a CAGR

According to DelveInsight's analysis, The Electrophysiology Devices Market is experiencing notable growth, driven by the rising incidence of chronic conditions such as cardiovascular diseases, including atrial fibrillation and coronary artery disease (CAD). This growth is further supported by the shift toward minimally invasive procedures, innovative product development by key industry players, and an expanding geriatric population, all of which are expected to boost the market from 2024 to 2030.

DelveInsight's "Electrophysiology Devices Market Insights, Competitive Landscape and Market Forecast-2030" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Electrophysiology Devices companies actively working in the market.

To know more about why North America is leading the market growth in the Electrophysiology Devices market, get a snapshot of the report Electrophysiology Devices Market Trends
https://www.delveinsight.com/sample-request/electrophysiology-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Electrophysiology Devices Overview
Electrophysiology devices are specialized medical instruments used to diagnose and treat heart rhythm disorders (arrhythmias). They help map the electrical activity of the heart, identify abnormal conduction pathways, and deliver targeted treatments such as ablation. These devices include electrophysiology catheters, mapping systems, ablation systems, and related accessories, and are commonly used in procedures performed in cardiac electrophysiology labs to restore normal heart rhythm and improve patient outcomes.

DelveInsight Analysis: The Electrophysiology Devices Market, valued at USD 6.31 billion in 2023, is projected to grow at a CAGR of 9.73% from 2024 to 2030, reaching approximately USD 9.22 billion by 2030.

Electrophysiology Devices Market Insights
Geographically, North America is projected to capture a substantial share of the electrophysiology devices market, driven by the high prevalence of coronary artery disease, myocardial infarctions, and other cardiac conditions, along with related cardiovascular risk factors. Additionally, significant advancements in product innovation and increased regulatory approvals are key contributors to market growth in the region from 2024 to 2030.

To read more about the latest highlights related to Electrophysiology Devices, get a snapshot of the key highlights entailed in the Electrophysiology Devices
https://www.delveinsight.com/report-store/electrophysiology-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Electrophysiology Devices Market Report
• In April 2025, LUMA Vision Ltd. announced FDA clearance for its VERAFEYETM Visualization Platform. This catheter-based imaging system offers real-time, 360-degree visualization in two and four dimensions, enhancing precision during electrophysiology and structural heart procedures. It is also prepared for magnetic tracking and navigation of third-party catheters.
• In May 2024, Implicity, a leader in remote patient monitoring and cardiac data management, received FDA 510(k) clearance for SignalHF1, an innovative new algorithm within their remote monitoring solution.
• In July 2023, Biosense Webster, Inc., announced the U.S. launch of the OPTRELLTM Mapping Catheter with TRUErefTM Technology, powered by the CARTO® 3 System. The OPTRELLTM Mapping Catheter was introduced as a high-density diagnostic tool, featuring a fixed array of small electrodes that delivered high-definition electrophysiological mapping for complex cardiac arrhythmia cases, including persistent atrial fibrillation (AFib), redo AFib ablation, atrial tachycardia, and ventricular tachycardia.
• In February 2023, Abbott secured approvals for two new electrophysiology products. It obtained the CE mark for the TactiFlex Ablation Catheter, SE, and received FDA approval for the Flexibility Ablation Catheter, SE.
• Thus, owing to such developments in the market, rapid growth will be observed in the Electrophysiology Devices market during the forecast period

Key Players in the Electrophysiology Devices Market
Some of the key market players operating in the Electrophysiology Devices market include- Boston Scientific Corporation, Lepu Medical Technology Co. Ltd., GENERAL ELECTRIC COMPANY, Medtronic, Abbott, BIOTRONIK, Microport Scientific Corporation, Acutus Medical Inc., Imricor, Johnson & Johnson Services, Inc., Baylis Medical Company Inc., Schwarzer Cardiotek GmbH, ATRICURE, INC., CardioFocus, Osypka AG, and others.

Which MedTech key players in the Electrophysiology Devices market are set to emerge as the trendsetter explore @ Key Electrophysiology Devices Companies
https://www.delveinsight.com/sample-request/electrophysiology-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Electrophysiology Devices Market Landscape
Within the diagnostic devices segment, ECG monitors remain the most widely used tools for cardiac monitoring. Commonly found in hospital settings, they have long been the conventional and preferred method for assessing patients' heart health. As one of the oldest available technologies, ECG monitors are cost-effective for healthcare providers, making the procedure affordable for patients as well. Moreover, ECG tests serve as an essential first step when cardiac issues are suspected, providing critical results that guide further advanced testing or inform treatment decisions.

The broad applications and benefits of such diagnostic devices improve performance and usability, significantly contributing to the overall market expansion during the forecast period from 2024 to 2030.

Scope of the Electrophysiology Devices Market Report
• Coverage: Global
• Study Period: 2021-2030
• Electrophysiology Devices Market Segmentation By Treatment Devices Type: Defibrillators, Pacemakers, Cardiac Resynchronization Therapy Devices, Ablation Systems [Radiofrequency, Cryoablation, and Others], and Others
• Electrophysiology Devices Market Segmentation By Diagnostic Devices: ECG Monitors [Stress, Rest, and Holter Monitors], EP X-Ray Systems, EP Recording Systems, EP Imaging & Mapping Systems, Implantable Cardiac Monitors, and others
• Electrophysiology Devices Market Segmentation By Application: Electrophysiology Devices Market Segmentation By End User: Hospital & Retail Pharmacy, E-Commerce, and others
• Electrophysiology Devices Market Segmentation By End User: Hospitals, Ambulatory Surgical Centers, and others
• Electrophysiology Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Electrophysiology Devices Companies: Boston Scientific Corporation, Lepu Medical Technology Co. Ltd., GENERAL ELECTRIC COMPANY, Medtronic, Abbott, BIOTRONIK, Microport Scientific Corporation, Acutus Medical Inc., Imricor, Johnson & Johnson Services, Inc., Baylis Medical Company Inc., Schwarzer Cardiotek GmbH, ATRICURE, INC., CardioFocus, Osypka AG, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Electrophysiology Devices market will grow by 2030? Click to get a snapshot of the Electrophysiology Devices Market Analysis
https://www.delveinsight.com/sample-request/electrophysiology-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Electrophysiology Devices Market to grow at a CAGR of 9.73% by 2030, Evaluates DelveInsight here

News-ID: 4146752 • Views:

More Releases from DelveInsight Business Research

Limbal Stem Cell Deficiency Market to Surpass USD 2.6 Billion by 2034, Driven by 240,000+ Diagnosed Cases Across 7MM, estimates DelveInsight
Limbal Stem Cell Deficiency Market to Surpass USD 2.6 Billion by 2034, Driven by …
In 2023, the Limbal Stem Cell Deficiency (LSCD) market was dominated by the United States, generating nearly USD 1.5 billion in revenue, while Spain represented the smallest market with approximately USD 127 million. This regional distribution is expected to remain consistent throughout the forecast timeline. The US accounted for nearly 103,000 diagnosed LSCD cases, whereas Japan recorded around 37,000 cases, with both countries projected to witness notable growth in patient
SSc-ILD Market Set to Cross USD 750 Million by 2034, Driven by 10+ Emerging Therapies, estimates DelveInsight
SSc-ILD Market Set to Cross USD 750 Million by 2034, Driven by 10+ Emerging Ther …
The major players operating in the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market include Roche, Prometheus Biosciences, Inc., Merck, GlaxoSmithKline, Genentech, Inc., Acceleron, Boehringer Ingelheim, Actelion, Hôpital Claude-Huriez, Changchun GeneScience Pharmaceutical, among others. DelveInsight's report titled "Systemic Sclerosis-associated Interstitial Lung Disease Market Insights, Epidemiology, and Forecast-2034" delivers a comprehensive analysis of SSc-ILD, covering historical data, projected epidemiology, and evolving market trends across the United States, EU4 (Germany, Spain, Italy, and France),
Developmental and Epileptic Encephalopathy Treatment Market Poised for Accelerated Expansion, Fueled by Targeted Therapies and a Growing Innovation Pipeline, Says DelveInsight
Developmental and Epileptic Encephalopathy Treatment Market Poised for Accelerat …
The Developmental and Epileptic Encephalopathy (DEE) treatment market across the seven major markets (7MM) was valued at nearly USD 2.1 billion in 2023 and is expected to register a healthy compound annual growth rate over the forecast period. The United States emerged as the largest contributor, capturing close to 80% of the overall market revenue. The DEE treatment landscape is undergoing a significant transformation as the limitations of traditional antiepileptic drugs
Polycythemia Vera Pipeline and Drug Development in 2025: 10+ Therapies and 8+ Companies Reshaping the Treatment Landscape, estimates DelveInsight
Polycythemia Vera Pipeline and Drug Development in 2025: 10+ Therapies and 8+ Co …
DelveInsight's "Polycythemia Vera Pipeline Insight 2025" report delivers an in-depth overview of the Polycythemia Vera pipeline landscape, covering more than 8 companies and 10+ pipeline candidates. The report analyzes both clinical-stage and preclinical assets, offering detailed drug profiles across various stages of development. It also evaluates Polycythemia Vera therapies based on product classification, development stage, route of administration, and molecular category, while additionally spotlighting inactive or discontinued pipeline assets. Explore the

All 5 Releases


More Releases for Devices

Spinal Fusion Devices Market Size to Reach Valuation of $7.43 Billion by 2022 | …
Increase in adoption of minimally invasive spine surgery (MISS) presents lucrative opportunities for key players in the spinal fusion devices market. MISS is preferred to conventional techniques, owing to its associated benefits such as minimal cut or incision, which in turn reduces the chances of damage caused to the adjacent muscles. Spinal fusion devices market was valued at $5,867 million in 2015, and is projected to reach $7,435 million by 2022,
Global Beauty Devices Market Industry Insights Forecast to 2024, Coverage Cellul …
The global beauty devices market was valued at USD 39.1 billion in 2018 and is anticipated to grow at a CAGR of 18.4% during the forecast period. The significant growth in the beauty devices industry is imputed to the rise in prevalence of skin disorders, increasing rate of hormonal imbalance cases, an increase in the geriatric population, and growing awareness for beauty devices. Request for Free Sample Copy of this Research
Canada Anesthesia and Respiratory Devices Market Segments Including Airway Manag …
ReportsnReports added a new report on The Canada Anesthesia and Respiratory Devices Market report that delivers the clean elaborated structure of the Report comprising each and every business-related information of the market at a global level. The in-depth study on the current state which focuses on the major drivers and restraints for the key players. Canada Anesthesia and Respiratory Devices Market Industry research report provides granular analysis of the market
Global Beauty Devices Market Insights 2018 By Products Hair Growth Devices,Acne …
Description This report studies the global market size of Beauty Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Beauty Devices in these regions. This research report categorizes the global Beauty Devices market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers,
Wearable Electronic Devices Market,Wearable Electronic Devices Industry, Global …
Latest industry research report on: Global Wearable Electronic Devices Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report studies the global Wearable Electronic Devices market status and forecast, categorizes the global Wearable Electronic Devices market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in United States, Europe, China, Japan, South Korea and Taiwan and other
Ophthalmic Devices Market By Product Function [Ophthalmic Surgery Devices (Refra …
Ophthalmology is a branch of medical sciences that deals with the structure, function, and various eye diseases. The ophthalmic devices are medical equipment designed for diagnosis, surgical, and vision correction purposes. These devices gain increased importance and adoption due to high prevalence of various ophthalmic diseases such as glaucoma, cataract, and other vision related issues. Request Sample At: https://www.bigmarketresearch.com/request-sample/1074435 Increase in prevalence rate of eye related diseases such as glaucoma, cataract,